Pharmx Technologies Ltd (PHX) - Total Liabilities
Based on the latest financial reports, Pharmx Technologies Ltd (PHX) has total liabilities worth AU$2.90 Million AUD (≈ $2.05 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmx Technologies Ltd - Total Liabilities Trend (1989–2025)
This chart illustrates how Pharmx Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Pharmx Technologies Ltd to evaluate short-term liquidity relative to the company's equity base.
Pharmx Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Pharmx Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heidelberger Beteiligungsholding AG
F:IPOK
|
Germany | €276.00K |
|
Mereo BioPharma Group PLC ADR
NASDAQ:MREO
|
USA | $6.56 Million |
|
Thai Solar Energy Public Company Limited
BK:TSE
|
Thailand | ฿3.91 Billion |
|
Bintang Samudera Mandiri Lines Tbk PT
JK:BSML
|
Indonesia | Rp96.90 Billion |
|
Suratwwala Business Group Limited
NSE:SBGLP
|
India | Rs1.27 Billion |
|
YM Tech Co. Ltd.
KQ:273640
|
Korea | ₩4.19 Billion |
|
Emperor Energy Ltd
AU:EMP
|
Australia | AU$426.64K |
Liability Composition Analysis (1989–2025)
This chart breaks down Pharmx Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Pharmx Technologies Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.41 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmx Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmx Technologies Ltd (1989–2025)
The table below shows the annual total liabilities of Pharmx Technologies Ltd from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.90 Million ≈ $2.05 Million |
-79.14% |
| 2024-06-30 | AU$13.88 Million ≈ $9.82 Million |
-2.96% |
| 2023-06-30 | AU$14.31 Million ≈ $10.12 Million |
+89.12% |
| 2022-06-30 | AU$7.57 Million ≈ $5.35 Million |
-10.11% |
| 2021-06-30 | AU$8.42 Million ≈ $5.96 Million |
+40.73% |
| 2020-06-30 | AU$5.98 Million ≈ $4.23 Million |
+19.24% |
| 2019-06-30 | AU$5.02 Million ≈ $3.55 Million |
-8.78% |
| 2018-06-30 | AU$5.50 Million ≈ $3.89 Million |
-4.88% |
| 2017-06-30 | AU$5.78 Million ≈ $4.09 Million |
-5.55% |
| 2016-06-30 | AU$6.12 Million ≈ $4.33 Million |
-16.41% |
| 2015-06-30 | AU$7.32 Million ≈ $5.18 Million |
-12.51% |
| 2014-06-30 | AU$8.37 Million ≈ $5.92 Million |
-6.56% |
| 2013-06-30 | AU$8.96 Million ≈ $6.34 Million |
-6.72% |
| 2012-06-30 | AU$9.60 Million ≈ $6.79 Million |
-36.99% |
| 2011-06-30 | AU$15.24 Million ≈ $10.78 Million |
-9.84% |
| 2010-06-30 | AU$16.90 Million ≈ $11.96 Million |
-0.49% |
| 2009-06-30 | AU$16.99 Million ≈ $12.02 Million |
-22.44% |
| 2008-06-30 | AU$21.90 Million ≈ $15.50 Million |
+13.91% |
| 2007-06-30 | AU$19.23 Million ≈ $13.61 Million |
-0.22% |
| 2006-06-30 | AU$19.27 Million ≈ $13.64 Million |
+3.18% |
| 2005-06-30 | AU$18.68 Million ≈ $13.22 Million |
-21.71% |
| 2004-06-30 | AU$23.86 Million ≈ $16.88 Million |
+35.96% |
| 2003-06-30 | AU$17.55 Million ≈ $12.42 Million |
+40.13% |
| 2002-06-30 | AU$12.52 Million ≈ $8.86 Million |
+17.90% |
| 2001-06-30 | AU$10.62 Million ≈ $7.52 Million |
+39.08% |
| 2000-06-30 | AU$7.64 Million ≈ $5.40 Million |
+21.56% |
| 1999-06-30 | AU$6.28 Million ≈ $4.44 Million |
+2747.49% |
| 1998-06-30 | AU$220.61K ≈ $156.10K |
-32.13% |
| 1997-06-30 | AU$325.06K ≈ $230.00K |
-96.05% |
| 1995-06-30 | AU$8.23 Million ≈ $5.82 Million |
-10.65% |
| 1994-06-30 | AU$9.21 Million ≈ $6.51 Million |
+397.35% |
| 1993-06-30 | AU$1.85 Million ≈ $1.31 Million |
+118.79% |
| 1992-06-30 | AU$846.00K ≈ $598.60K |
-19.12% |
| 1991-06-30 | AU$1.05 Million ≈ $740.11K |
+0.67% |
| 1990-06-30 | AU$1.04 Million ≈ $735.16K |
+6.13% |
| 1989-06-30 | AU$979.00K ≈ $692.70K |
-- |
About Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more